SCHEMBL6043987

SCHEMBL6043987

O=C(O)c1c(F)c(F)c2c(nnn2C(C(F)(F)F)C(F)(F)F)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6044534 0.76 HCAR3 (0.35)
SCHEMBL6043860 0.73
SCHEMBL6044683 0.71 HCAR3 (0.36)
SCHEMBL6044124 0.70 KDM4E (0.34)
SCHEMBL6044841 0.69 HCAR3 (0.38)
SCHEMBL6044422 0.67 HCAR3 (0.40)
SCHEMBL141037 0.62 CYP1A2 (0.40)
Fluoride SCHEMBL2393600 0.60 CYP1A2 (0.38)
Hydrochloric Acid SCHEMBL4414501 0.60 CYP1A2 (0.38)
Hydrochloric Acid SCHEMBL7881715 0.60 CYP1A2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122240-A1 Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof ARENA PHARMACEUTICALS, INC. (US) 2006-06-08 US disclosed